Related Experiment Video
Updated: Mar 24, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
15.2K
Gemfibrozil in Combination with Statins-Is It Really Contraindicated?
Barbara S Wiggins1, Joseph J Saseen2,3, Pamela B Morris4
1Department of Pharmacy Services, Medical University of South Carolina, 25 Courtenay Drive, MSC 584, Charleston, SC, USA. wiggib@musc.edu.
Current Atherosclerosis Reports
|March 3, 2016
Summary
Gemfibrozil, a fibric acid derivative, effectively lowers high triglyceride levels and improves cholesterol profiles. Despite concerns about muscle-associated side effects, it may be necessary in combination with statins for certain patients.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Lipid Metabolism
Background:
- Gemfibrozil is a fibric acid derivative that activates peroxisome proliferator activated receptor α (PPAR-α).
- It is primarily used to manage hypertriglyceridemia, with potential triglyceride reductions up to 74%.
Purpose of the Study:
- To review the role of gemfibrozil in lipid modification.
- To discuss its efficacy in lowering triglycerides, VLDL-C, and LDL-C, and raising HDL-C.
- To address the clinical considerations and safety of gemfibrozil, particularly in combination with statins.
Main Methods:
- Literature review of gemfibrozil's mechanism of action, clinical applications, and adverse effects.
- Analysis of guidelines regarding triglyceride management thresholds (≥500 mg/dL).
- Examination of drug interactions, specifically with statins.
Main Results:
- Gemfibrozil effectively reduces triglycerides, VLDL-C, and LDL-C, while increasing HDL-C.
- Muscle-associated adverse effects are the primary reason for its decreased use.
- Combination therapy with statins may be indicated in specific clinical scenarios.
Conclusions:
- Gemfibrozil remains a viable option for managing severe hypertriglyceridemia.
- Understanding gemfibrozil metabolism and statin interactions is crucial for optimizing safety in combination therapy.
More Related Videos
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
01:30Drug toxicity: Drug–Drug Interaction
316
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
316
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
845
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
845
01:25Pharmacokinetics: Drug–Drug Interactions
640
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
640
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
464
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
464
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
1.0K
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
1.0K